Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Masanori Umeda
Observed names:
M Umeda,
M. Umeda,
Masanori UMEDA
Institution:
Toho University
Observed institutions:
Toho University,
Okayama University,
Toho University Omori Medical Center,
Saitama Cancer Center,
National Defense Medical College
OpenAlex ID:
A5078749313
Prognostic Implications of the Differentiation Inhibitory Factornm23-H1 Protein in the Plasma of Aggressive Non-Hodgkin’s Lymphoma
1999
·
Nozomi Niitsu
, Junko Okabe-Kado
, et al.
·
Blood
·
46
Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia
2000
·
Nozomi Niitsu
, Junko Okabe-Kado
, et al.
·
Blood
·
45
AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells.
1997
·
N Niitsu
, Y Yamamoto-Yamaguchi
, et al.
·
PubMed
·
36
Human Monocytoid Leukemia Cells Are Highly Sensitive to Apoptosis Induced by 2′-Deoxycoformycin and 2′-Deoxyadenosine: Association With dATP-Dependent Activation of Caspase-3
1998
·
Nozomi Niitsu
, Yuri Yamaguchi
, et al.
·
Blood
·
33
Anticancer Derivative of Butyric Acid (Pivalyloxymethyl Butyrate) Specifically Potentiates the Cytotoxicity of Doxorubicin and Daunorubicin through the Suppression of Microsomal Glycosidic Activity
2000
·
Nozomi Niitsu
, Takashi Kasukabe
, et al.
·
Molecular Pharmacology
·
32
A high serum soluble Fas/APO-1 level is associated with a poor outcome of aggressive non-Hodgkin’s lymphoma
1999
·
N Niitsu
, K Sasaki
, et al.
·
Leukemia
·
31
Evaluation of Long-Term Daily Administration of Oral Low-Dose Etoposide in Elderly Patients with Relapsing or Refractory Non-Hodgkin's Lymphoma
1997
·
Nozomi Niitsu
, Masanori Umeda
·
American Journal of Clinical Oncology
·
27
Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor
1993
·
M. Katoh
, K. Shikoshi
, et al.
·
Annals of Hematology
·
27
Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs
2000
·
Nozomi Niitsu
, Masanori Umeda
, et al.
·
Leukemia Research
·
25
Prognostic significance of the serum phosphorus level and its relationship with other prognostic factors in multiple myeloma
2006
·
Masanori Umeda
, Shinya Okuda
, et al.
·
Annals of Hematology
·
24
THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for non-Hodgkin’s lymphoma in elderly patients: a prospective study
1997
·
N Niitsu
, M Umeda
·
Leukemia
·
20
Response and adverse drug reactions to combination chemotherapy in elderly patients with aggressive non‐Hodgkin's ymphoma: comparison of CHOP, COP‐BLAM, COP‐BLAM III, and THP‐COPBLM
1999
·
Nozomi Niitsu
, Masanori Umeda
·
European Journal Of Haematology
·
17
Induction of Differentiation of Human Myeloid Leukemia Cells by 2′-Deoxycoformycin in Combination with 2′-Deoxyadenosine
1997
·
Nozomi Niitsu
, Masanori Umeda
, et al.
·
Biochemical and Biophysical Research Communications
·
17
IgD myeloma indicated by plasma cells in the peripheral blood and massive pleural effusion
2008
·
Kazuhiko Natori
, Haruka Izumi
, et al.
·
Annals of Hematology
·
16
PDF
Double Cancer in Elderly Patients with Hematologic Malignancies.
1996
·
Nozomi Niitsu
, Masanori Umeda
·
Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
·
15
PDF
Antileukemic efficacy of 2′-deoxycoformycin in monocytic leukemia cells
2000
·
Nozomi Niitsu
, Yuri Yamamoto-Yamaguchi
, et al.
·
Blood
·
14
PDF
Biweekly COP‐BLAM (cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine) regimen combined with granulocyte colony‐stimulating factor (G‐CSF) for intermediate‐grade non‐Hodgkin's lymphoma
1996
·
Nozomi Niitsu
, Masanori Umeda
·
European Journal Of Haematology
·
12
Salvage chemotherapy for relapsed or refractory non‐Hodgkin's lymphoma with a combination of ACES (high‐dose Ara C, carboplatin, etoposide and steroids) therapy
1996
·
N. Niitsu
, M. Umeda
·
European Journal Of Haematology
·
11
Pulmonary Toxicity During Granulocyte Colony Stimulating Factor Administration and Neutrophils
1996
·
Masako Katoh
, Masafumi Takada
, et al.
·
CHEST Journal
·
11
Bone lesions in elderly multiple myeloma.
2002
·
Masanori Umeda
, Yamao Adachi
, et al.
·
Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
·
10
PDF
COP‐BLAM regimen combined with granulocyte colony‐stimulating factor and high‐grade non‐Hodgkin's lymphoma
1995
·
N. Niitsu
, M. Umeda
·
European Journal Of Haematology
·
9
Neplanocin A, a potent inhibitor of S-adenosylhomocysteine hydrolase, potentiates granulocytic differentiation of acute promyelocytic leukemia cells induced by all-trans retinoic acid.
1997
·
N Niitsu
, Y Yamamoto-Yamaguchi
, et al.
·
PubMed
·
8
Fungemia in Patients with Hematologic Malignancies: Therapeutic Effects of Concomitant Administration of Fluconazole and Granulocyte-Colony-Stimulating Factor
2009
·
Nozomi Niitsu
, Masanori Umeda
·
Chemotherapy
·
7
Biweekly THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for intermediate- and high-grade non-Hodgkin's lymphoma
1998
·
N Niitsu
, M Umeda
·
Leukemia
·
7
A phase II study of epirubicin in acute leukemia: a cooperative group study.
1987
·
K Sampi
, T Masaoka
, et al.
·
PubMed
·
7
Show more works
View as search
Works count:
89
Citation count:
571
H-index:
15
I10-index:
20
Year
Topic
Type
